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In order to study extrathymic differentiation in vitro, CD7/CD3 lymphocytes were
sorted from normal human bone marrow and cultured under conditions of limiting
dilution together with irradiated pooled allogeneic peripheral blood mononuclear cells
(PBMC) and phytohemagglutinin (PHA) in the presence of 1000 U/ml of interleukin-2
(IL-2). One clone was obtained that failed to react with monoclonal antibody (mAb)
TCR (TCR1, ,/-specific) or WT31 (TCR2, o/fl-specific). From day 35 through day 74
in culture, the surface phenotype of this clone evolved into CD3/, CD4/, CD8-, TCR2/,
TCRI-, and was further characterized as CD2/, CD45RO/, CD16-, and CD56-. The pres-
ence of mRNA for TCR o and ]/but not ,and c chains was confirmed by Northern blot-
ting. Accessory cell-dependent autocrine proliferative responses to PHA (most likely
driven by IL-2) were initially absent, but became measurable at the same time as the
TCR was acquired. However, in the absence of PHA, the clone failed to respond to a
panel of homozygous B-cell lines representing the majority of MHC class II alleles.
Autoreactivity was also not demonstrable. Cytotoxicity was limited to MHC unrestric-
ted "natural killer (NK)-like" lysis of K562 target cells, with no autocytotoxicity
detected. Tle NK-like lysis diminished over time in parallel with the acquisition of sur-
face TCR. The cloned cells were not suppressive for mature lymphocyte proliferation.
After stimulation, the cells secreted tumor necrosis factor o and
granulocyte/macrophage colony-stimulating factor (GM-CSF) detected by immuno-
assays, and T-cell growth factors, most likely IL-2, as detected by bioassays. Polymerase
chain-reaction methods demonstrated the presence of mRNA for IL-2, IL-3, IL-4, IL-9,
interferon-y, and GM-CSF in these cells after stimulation with PHA and B-LCL.
These results suggest that cells with the phenotype and some functional character-
istics of mature T lymphocytes can evolve extrathymically in vitro from T-cell precursors
sorted from normal human bone marrow.
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INTRODUCTION
T-cell precursors arise in the bone marrow, from
where they must migrate to the thymus via per-
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ipheral blood. That the thymus is important for
the generation of the mature T lymphocytes, for
which both positive and negative selection of
developing T cells is required, is demonstrated
by their virtual absence in young congenitally
athymic rats, mice, and di George Syndrome
patients. However, it is not clear whether the thy-
mus is absolutely necessary for the T-cell differ-
entiation process, because older athymic rodents
do possess limited numbers of both TCR1 (,/
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receptor+) and TCR2 (o/fl-receptor/) T lympho-
cytes (Benveniste et al., 1990; Sarawar et al.,
1991). Moreover, analysis of such cells after long-
term alloantigen-stimulated culture indicated the
presence of functional cytokine-secreting auto-
reactive and alloreactive T cells (Abromson-
Leeman et al., 1990), although in vivo function
may nonetheless be severely compromised
(Sarawar et al., 1991). Taken together, these
results suggest that extrathymic T-cell generation
resulting in functionally competent cells may
occur, but the possibility remained that even
athymic rodents might retain thymic rudiments
that could influence T-cell maturation.
Several lines of evidence suggest that extrathy-
mic maturation may also occur in man. Early
data suggested that peripheral blood mono-
nuclear cells (PBMC) stringently depleted of T
cells formed colonies that rapidly acquired sur-
face CD3 in semisolid agar cultures (Triebel et al.,
1981) and in liquid cultures under limiting
dilution conditions (Moreau and Miller, 1983).
Peripheral lymphocytes expressing an early T-
cell marker, CD7, but lacking the T-cell receptor
(TCR) for antigen, were found slowly to acquire
CD3 and TCR when cultured with interleukin
(IL-2), phytohemagglutinin (PHA), and allo-
geneic cells (Preffer et al., 1989). However, it was
pointed out that it could not be excluded that
these peripheral cells had been exposed to the
thymus, but had "ecaped" without processing.
To exclude this, Hori and co-workers (1991) cul-
tured CD3- human fetal liver cells with PHA and
allogeneic cells and reported the generation of T
cells with both mature (surface CD3/) as well as a
variety of immature (cytoplasmic CD3/) pheno-
types. In another series of studies by a different
group, cells of the same phenotype derived from
bone marrow (BM) cultured with PHA-con-
ditioned medium began to acquire CD3 as early
as day 3 (Bertho et al., 1990). In a different
approach, CD7/CD3 human BM cells cultured in
agar were shown to form colonies expressing
CD3 after only a week (Lecron et al., 1989), pro-
vided that cultures were supplemented with fac-
tors additional to IL-2 (Mossalayi et al., 1985).
Taken together, these and other results suggest
that pre-T cells in BM and possibly also PBMC
can develop extrathymically into cells carrying
the phenotypes of mature thymic-processed T
lymphocytes. It might be predicted that such
cells would differ from postthymic clones in their
functions and specificities, particularly autoreac-
tivity. So far, this appears not to have been inves-
tigated. We therefore undertook a study on the
functional characteristics of T-cell clones (TCC)
generated from CD7/CD3 cells in normal BM.
RESULTS
Surface-Marker Phenotyping and Nature of
the TCR
CD3-CD7+ BM cells from two healthy donors
were cloned by limiting dilution in the presence
of allogeneic PBMC, PHA, and IL-2. Cloning
efficiencies were 17% and 18%, yielding 19 and
17 T-cell clones, respectively. The surface pheno-
types of these TCC were established at the
earliest time point possible (days 23 to 35). With
one exception, all clones stained strongly with
mAb OKT3 and WT31 (data not shown). Most of
these were not studied further here. One clone,
designated 314-14, failed to stain with mAb
WT31 and stained only weakly with OKT3 at the
earliest time point tested (day 35). At the next
time point tested, culture day 56, the phenotype
had changed radically. About half the cells had
acquired bright staining with WT31, and there
was a separate peak of less strongly staining cells
as well as a small population that remained com-
pletely negative (Fig. 1). The pattern of CD3
expression paralleled that of WT31 (Fig. 1) and
there was no staining with mAb TCR (not
shown). By day 65, almost all cells stained
brightly with both OKT3 and WT31, but there
was still a small population of more weakly
staining cells. This had completely disappeared
by day 74 (Fig. 1). Cells were also tested with
mAb to polymorphic determinants carried by
TCR V]/chains at days 56 and 73, but failed to
stain with V]/5, 6 or 8-specific mAb (data not
shown). The cells stained homogeneously
brightly with CD2 and CD7 mAb at all four time
points tested (data not shown). Because 314-14
was unique in appearance and behavior, the
question of its origin arose (abnormal mutated
cell derived from irradiated filler cells?). There-
fore, PBMC from the donor, clone 314-14 and
another T-cell clone from the same donor were
subjected to HLA class I serotyping using comp-
lement previously absorbed with other T-cell
clones from the same individual. They all199200 H. POHLA et al.
expressed an identical HLA-A1, 25;-B8, 61;-Cw2,
Cw7 phenotype (data not shown) and therefore
can be taken as originating from the same donor.
The evolution of the CD4/8 phenotype of clone
314-14 was also followed. Initially, the clone
expressed very little if any CD4, but did express
CD8 in a continuously variable manner (Fig. 1).
By day 56, a separate bright peak and smaller
negative peak for CD4 became visible, with CD8
staining resulting in a reciprocal picture. The
level of CD8 staining became progressively less,
until by day 74, the clone was essentially
CD4/CD8 (Fig. 1).
Both at day 56 and day 73, clone 314-14 cells
strongly expressed the CD45RO isoform of the
leukocyte common antigen (median channel
intensity 169 and 122, respectively, compared
with background staining of 33 and 34,
respectively), but also expressed CD45RA (albeit
at the lower levels of 90 and 70, respectively).
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FIGURE 2. Northern blot analysis TCC 314-7 and 314-14 TCR mRNA. Hybridization was done with the TCR-o-chain-specific
probe pGA5 (A), the TCR]/-chain probe pCflREX (B), and with probes specific for TCR’(C) andTCR (D). Controls were JURKAT
T-ALL lines J3R7 and JHAN, and the immature T-cell lines HSB2 and PEER. The 18 and 28S rRNAs are indicated by the two
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They stained weakly for CD5 and CD25 (ca. 50
and 60 arbitrary units, respectively), and did not
express CD16 or CD56 (background staining).
The expression of mRNA for TCR o and fl
chains was confirmed using Northern blotting in
65-day-old cells. Figure 2 compares clone 314-14
with another clone from the same donor, 314-7,
which had already demonstrated a mature
phenotype at the earliest time point tested. The
same two clones were assessed in Southern blot-
ting at the same age for TCR gene rearrange-
ments. The result shown in Fig. 3 suggests
monoallelic rearrangements involving Cfll and
Cfl2 in clone 314-14, confirming monoclonality.
Hybridization with the TCR7 probe also indi-
cated J ?’1 and 2 rearrangements (data not shown).
Proliferative Capacity of Clone 314-14:
Response to Cytokines
Cells from clone 314-14 at culture days 56 and 74
were incubated together with IL-2, IL-3, IL-4, IL-
7, or GM-CSF for 42, 66, or 90 hr before assessing
proliferation by incorporation of 3H-TdR. The
results for peak incorporation (66 hr) are shown
in Fig. 4, suggesting that a major growth factor
for these cells is IL-2.
Proliferative Capacity of Clone 314-14:
Response to Cells
The autocrine proliferative capacity of clone 314-
14 cells was investigated by stimulating them
with B-LCL and 1% PHA in the absence of
exogenous cytokines. Thirty-five-day-old cells
were unable to respond. Fifty-six-day-old cells
responded very weakly, but 74-day-old cells pro-
liferated strongly (Fig. 5). Thus, acquisition of
autocrine proliferative capacity, triggered by the
nonspecific mitogen PHA, parallels the acqui-
sition of the TCR. However, stimulation by B-
LCL in the absence of PHA did not result in
autocrine proliferation (Fig. 5). An extended
panel of stimulating B-LCL covering most class II
alleles also failed to reveal alloreactivity of 314-
14 cells (data not shown).
It was of interest to investigate whether, in the
absence of the thymus, clone 314-14 cells had
retained autoreactivity during differentiation.
Stimulation of day 35, 56 and 74 cells with auto-
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FIGURE 3. Southern blot analysis of (A) EcoRI-, (B) BamHI-, or (C) HindIII-digested genomic DNA isolated from the TCC 314-7
and 314-14, hybridized with the cDNA probe pCflREX. The B-LCL (PEA) represents the germline configuration of 11 kb (Cfll
region) and 4 kb (Cfl2) for the EcoRI digest; 24 kb (Cfll and Cfl2) for the BamHI digest; and 7.5 kb (Cff2), 6.0 kb (Cfl2 3’ region),
and 3.3 kb (Cfll) for the HindIII digest. The JURKAT lines are included as positive controls for rearrangements on both alleles.202 H. POHLA et al.
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FIGURE 4. Proliferative responses of clone 314-14 to
cytokines. The cytokines were titrated over a wide
concentration range and a three time-point kinetic was
performed. Maximal response is shown as cpm+SEM of
triplicate cultures for IL-2 at 100 U/ml, IL-3 at 100 U/ml, IL-4
at 1000 U/ml, IL-7 at 50 U/ml, and GM-CSF at 50 U/ml, all
after 66 hr. One of two experiments is shown.
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Autocrine proliferative responses of clone 314-14.
A three time-point kinetic was performed, and the maximum
responses are shown (obtained at 66 hr). A large panel of B-
LCL (filled circles, n=46) representing essentially all common
MHC alleles was employed as stimulators, and a
representative result obtained with one of them is shown.
Response to the same LCL in the presence of 1% PHA (filled
triangles). Stimulation by irradiated autologous PBMC is
represented by open circles. Data are given as mean+SEM of
triplicates. One of four similar experiments is shown.
logous PBMC showed that this was not the case
(Fig. 5).
The nature of the growth factor required for
autocrine proliferation by 314-14 cells was inves-
tigated using neutralizing antibodies to IL-2.
Data displayed in Fig. 6 show that the prolifera-
tive response of the cells to PHA in the presence
of LCL accessory cells is inhibited by anti-IL-2
antibodies in a dose-dependent fashion, whereas
isotype-matched anti-IL-1]/(Fig. 6) or anti-IL-lo
(data not shown) had no effect on proliferation.
75
0 \\\\’I
23 5O
25
25 10 3.3 1.1 10 3.3 1.1 #g/ml
Ab: IL 2Ra onti-lL 2 onti-lL 1
FIGURE 6. Inhibition of clone 314-14 autocrine proliferation
with neutralizing IL-2 antibodies or CD25 mAb. Cells were
stimulated with PHA in the presence of LCL and titrated
amounts of IL-2 or IL-l-specific purified IgG antibodies, or
with 25% culture supernatant of the IL-2--chain-specific mAb
T069. Results are expressed as percent inhibitionSEM of
proliferation measured in the absence of antibody. One of two
experiments is shown.
Moreover, an mAb against the o chain of the IL-
2R also strongly blocked autocrine proliferation
of 314-14 cells. Taken together, these data suggest
that IL-2 is an important autocrine TCGF for
clone 314-14 cells.
Cytokine Production
A sensitive PCR technique was employed to
investigate further the production of cytokines
by 314-14 cells by assessing the presence of
mRNA after stimulation with PHA and B-LCL.
The presence of IL-2, IL-3, IL-4, IL-9, IFN- and
GM-CSF transcripts before and 5 hr after stimu-
lation was assessed on clone 314-14 and a num-
ber of other TCC from the same donor for com-
parison. The kinds of results obtained with this
technique are shown for the example of IL-9 in
Fig. 7 and summarized in Table 1. Sixty-five-day-
old clone 314-14 cells contained IL-2, IL-3, and
IFN-?’ mRNA only after stimulation, although 7
days after the previous stimulation in culture, IL-
4, IL-9, and GM-CSF transcripts were still
present.
TNF-o mRNA production could not be
measured by the technique described before,
because the stimulating B-cell lines were all posi-
tive in PCR for this cytokine. Supernatants from
cloned cells 48 hr after stimulation were therefore
assessed for TNF-o content in an immunoassay.HUMAN T-CELL DEVELOPMENT IN VITRO 203
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FIGURE 7. Southern blot analysis
of the IL-9-specific amplified prod-
uct of several TCC 7 days after
stimulation in culture (u) or
restimulated for 5 hr with 1% PHA
and irradiated LCL. RNA from
stimulated PBMC was used as a
positive control. RNA from the
human histiocytic lymphoma line
U937, and additionally the perform-
ance of the amplification process
without RNA served as negative
controls. (A) Gel analysis of the
amplified product (376 bp); M=mol-
ecular weight marker VI
(Boehringer). (B) Hybridization with
the IL-9-specific cDNA probe (kind
gift of J. van Snick).
TABLE
Cytokine Production by Clone 314-14
Clone Stimulated
IL-2
mRNA
IL-3 IL-4 IL-9 IFN-, GM-CSF
Proteinb BioassayC
GM-CSF TNF-o IL-2
314-14 No
Yes +
314-3 No
Yes +
314-12 No
Yes +
314-13 No
Yes +
314-18 No
Yes +
+ + +
+ + + + +
+ +
+ + + + +
+ + + + +
+ + + + +
+ + + + +
nt nt nt
180 2025 68
nt nt nt
71 750 45
nt nt nt
nt nt nt
nt nt nt
64 642 75
nt nt nt
nt nt nt
’mRNA measured by PCR.
bprotein measured by ELISA.
TCGF bioactivity measured IL-2-dependent T-cell clone.
ant=not tested.
Cells from clone 314-14 were found to produce
large amounts of TNF-o after stimulation.
Additionally, the presence of GM-CSF protein in
supernatants of stimulated 314-14 cells was dem-
onstrated (Table 1), showing that the message at
least for this cytokine was translated. T-cell
growth-factor activity detected in a bioassay on a
T-cell clone with weak or absent IL-4 reactivity,
and therefore presumably predominantly IL-2, is
also shown in Table 1. This result is consistent
with the antibody neutralization experiment
shown in Fig. 6.
Cytotoxicity
Lytic activity of clone 314-14 cells was assessed
on natural killer-susceptible K562 target cells in
the presence of PHA (to measure cytotoxic
potential) or absence of PHA (to measure MHC
unrestricted "natural killerlike" cytotoxicity). In204 H. POHLA et al.
TABLE 2
Cytotoxicity of Clone 314-14 at Different Ages
Age (days) Target cells
K562 K562+PHA Autol T cells
35 646 nt nt
56 41 4150 <0.1
65 <0.1 195 <0.1
73 <0.1 103 <0.1
74 <0.1 337 <0.1
aResults given lytic units (25%) per 10 cells 2000 targets (three
ex_eriments).
nt=not tested.
addition, PHA-stimulated T-cell blasts of the
clone donor were also used as targets to measure
autoreactivity. The results are summarized in
Table 2. 314-14 cells at day 35 were strongly lytic
on K562 targets in the presence of PHA.
Although the level of cytotoxicity varied over
time, it remained present up until day 74. Strong
NK activity of the clone, however, was observed
only on day 35, was very weak at day 56 and
thereafter was no longer seen. In contrast, auto-
cytotoxic activity was not observed at any age
(Table 2).
DISCUSSION
CD7, a member of the Ig superfamily, is an early
marker of the T-cell lineage, which is expressed
on fetal lymphocytes prior to colonization of the
thymus and prior to TCRfl-chain gene rearrange-
ment or expression of CD1, 2, or 3 (Lobach et al.,
1985; Haynes et al., 1988). It is retained on mature
cells, but its function is unknown. It may be
involved in both positive and negative (Carrera
et al., 1988; Emara et al., 1989; Costantinides et
al., 1991; Jung et al., 1992; Shimizu et al., 1992)
regulation of T-cell responses.
CD7
/ BM cells lacking surface expression of the
T-cell antigen receptor-associated CD3 structures
rapidly develop into CD3
/ colonies under appro-
priate culture conditions in semisolid media
(Lecron et al., 1989). This process requires
unidentified factors in addition to IL-2
(Mossalayi et al., 1985). Because at least the
majority of these BM cells are unlikely to have
experienced intrathymic passage, this system
offers a model for extrathymic differentiation in
man. However, the antigen-recognition reper-
toire and functions of this type of in vitro differ-
entiated cell seem not to have been investigated.
We set out to test some of the basic functional
attributes of T-cell clones derived from
CD7/CD3 BM cells using a liquid culture system.
Previous work by Preffer and co-workers (1989)
using cells of the same phenotype derived from
peripheral blood had shown their slow
(beginning at 40 days; complete by 85 days)
acquisition of CD3 positivity in uncloned lines in
liquid culture using high concentrations of
recombinant IL-2. The kinetics of acquisition of
TCR by cloned cells was not specified (Preffer et
al., 1989). Our results on clone 314-14 suggest a
similar TCR acquisition kinetic by at least some
CD7/CD3 BM cells of 50 to 60 days. That the
majority of clones we obtained was already CD3
/
by day 25 or so may be explained by (1) impurity
of cells in the sorted starting population, con-
sidered unlikely on the basis of theoretical calcu-
lations, but not directly excluded because we
could not reanalyze thrice-sorted cells; (2) the
isolation of postthymic cells that had returned to
the BM, or were contaminating it, and that had
for some reason modulated CD3/TCR at the time
of isolation; (3) the existence of a second type of
extrathymic differentiation pathway where the
TCR is acquired much more rapidly. The last
possibility is consistent with results obtained
using BM T-cell colony formation in agar (Triebel
et al., 1981; Mossalayi et al., 1985; Hallet et al.,
1989; Lecron et al., 1989; Mossalayi et al., 1990)
and liquid culture (Moreau and Miller, 1983), but
inconsistent with the PBMC-liquid culture sys-
tem of Preffer and co-workers (1989). Moreover,
recent results from Palathumpat and co-workers
(1992) showed that sorted mouse
CD4-CD8-TCR2- BM cells, which manifested
germline configurations for TCR-]/-chain genes,
very rapidly acquired TCR2 expression in culture
after only 2 days, and that this was accompanied
by rearrangements in the ]/-chain genes.
We present for the first time functional data on
cells with an apparently mature CD2+CD3
/
CD4+CD7/CD8-TCR2+ phenotype derived from
putative BM prethymic precursor T cells. These
cells were clearly capable of PHA-stimulated
autocrine proliferation once they had acquired a
mature TCR phenotype (strongly CD3/WT31+),
but not beforehand, even though PHA can trig-
ger cell proliferation via structures other than
exclusively by TCR (O’Flynn et al., 1985; Pantaleo
et al., 1988). Thus, such cells acquire proliferative
competence in parallel with the acquisition of theHUMAN T-CELL DEVELOPMENT IN VITRO 205
TCR. In contrast, it appeared that they los._.t NK-
like activity also in parallel with the acquisition
of the TCR, although their cytotoxic potential
was maintained. At no time point was it possible
to demonstrate autoreactivity, either in prolifer-
ation or cytotoxicity assays. Furthermore, no allo-
reactivity could be demonstrated in either test
system. These results may suggest: (1) the single
clone 314-14 happens to be specific for a particu-
lar antigen for which we did not test, or (2) the
differentiation of T cells in an environment con-
taining most or all MHC types (on the pooled
stimulators), plus PHA, leads to the deletion of
precursors potentially recognizing them and
allows only rare cells like 314-14 to escape
deletion. It is also important to note that we were
unable to show suppressive activity of these cells
in MLC, a property that distinguishes them from
the "natural suppressor" cells from BM, even
those that have acquired TCR expression
(Palathumpat et al., 1992).
Autocrine proliferative responses by 314-14
cells probably depended upon IL-2 as a growth
factor, because (1) IL-2 mRNA was present in
stimulated cells; (2) T-cell growth-factor activity
was secreted by the cells; (3) the cells responded
strongly to IL-2 but weakly or not at all to IL-4
and IL-7; and (4) PHA-stimulated autocrine pro-
liferation was substantially inhibited by anti-IL-2
and CD25 antibodies. However, it is not excluded
that IL-9 or IL-12 could act as growth factors for
these cells, particularly because IL-2 neutraliz-
ation did not result in complete suppression of
proliferation and because we demonstrated the
presence of IL-9 mRNA transcripts in 314-14
cells.
Cells from clone 314-14 were unique amongst
clones from the same donor (Table 1) or alloreac-
tive cells from other donors (data not shown) in
being the only ones to express the IL-4 message
without restimulation (i.e., 7 days after
stimulation). It has been reported that human
pro-T cells can synthesize IL-4 mRNA in the
absence of an exogenous stimulus (Barcena et al.,
1991), although it was suggested that these are
destined to become TCR1
/ cells, whereas 314-14
possesses TCR2. However, some CD7/CD3
human BM cells are clearly able to differentiate
into TCR2 T cells in vitro under the influence of
IL-2 combined with another unidentified factor
(Bertho et al., 1990), and 314-14 may therefore
have developed along this pathway. The pres-
ence of IL-2 may favor the development of TCR2
/
cells, whereas IL-4 or IL-7, not added to our cul-
ture system, may favor the differentiation of
TCR1
/ cells (Barcena et al., 1991; Watanabe et al.,
1991).
These results suggest that the approach pre-
sented here may represent a viable model for
studies of human T-cell differentiation in vitro.
However, it must be emphasized that the present
culture technique resulted in the isolation of only
a single clone, the differentiation of which could
be followed in this way in vitro, and that this
therefore may not necessarily be representative
of extrathymic differentiation pathways. Further
work aimed at improving the yield of such clones
is required to resolve this question. Nonetheless,
the ability to use this technique to explore possi-
bilities to manipulate extrathymic differentiation
of BM-derived T-cell precursors may be useful in
the context of marrow transplantation in adults,
where patients commonly possess minimal thy-
mic function due to conditioning and age. Both
long-lasting depressed T-cell function and
manifestations of autoimmunity in chronic graft
versus host disease may be reflections of inef-
ficient thymic function, and be susceptible to
manipulations aimed at influencing extrathymic
differentiation.
MATERIALS AND METHODS
Cell Separations
Prior to staining, 4x107 BMMC were preincu-
bated with human gamma-globulin (Intraglobin,
Biotest, Frankfurt) for 10min. After washing,
cells were incubated with OKT3 (ATCC, CD3,
IgG2a) and TO 93 (Tbingen local, CD7, IgG2b)
for 15 min. After repeated washing, the cells
were incubated with goat anti-mouse IgG2a-PE
and goat anti-mouse IgG2b-FITC (Southern
Biotechnology). Prior to sorting CD7/CD3 cells
with a FACS IV, a lymphocyte window was set
by dual scatter parameters. The green fluor-
escence of FITC-labeled cells was measured
through a 530-nm band-pass filter (Becton-
Dickinson) and the yellow fluorescence of the PE-
labeled antibodies through a 570-nm band-pass
filter (Oriel). The yellow and green components
of the emitted light were separated by a beam
splitter with a dichroic (560-nm) filter. A206 H. POHLA et al.
differential log amplifier was used to correct for
the overlap of the green fluorescence emission
spectrum of FITC into the yellow fluorescence
emission spectrum of PE. The amplifier was
adjusted so that the signal from cells stained only
with FITC was orthogonal to the yellow fluor-
escence axis of the two-parameter yellow and
green fluorescence display. For cell sorting, the
sort window was set on the CD7/CD3 popu-
lation. One-droplet sorting without "full deflec-
tion envelope (coincidence)" was performed at a
20-kHz droplet formation rate (diameter of
nozzle orifice was 80 tm). Cells were sorted into
sterile tubes containing 20% FCS in Hanks’ buffer
and resorted twice in the same way. No CD3
/
cells could be found in 5000 reanalyzed cells
from the CD7/CD3 population. The enrichment
factor for CD3-CD7
/ cells at each sort was esti-
mated at x30, yielding a calculated purity of
>99.9% after three sorts. There were too few cells
available for restaining and reanalysis. The num-
ber of CD3-CD7 cells initially present in the BM
samples was estimated at ca. 0.5% rather more
than reported previously (Bertho et al., 1990).
for CD45RA (IOL2), CD45RO (UCHL1), and
CD16 (ION16) were purchased from Dianova
GmbH, Hamburg, and CD56 (Leu19) was from
Becton-Dickinson (Erembodegem, Belgium). The
TCR mAb reacting with nonpolymorphic
determinants of the TCR chain, and the WT31
mAb reacting with TCR components predomi-
nantly of o/]/-TCR were kind gifts of Dr. M.
Brenner, Boston, and Dr. W. Tax, Nijmegen, the
Netherlands, respectively. MAb specific for TCR
V]/ families were C37 [V//5.3 (Posnett et al.,
1988)], OT145 [V]/6.7 (Posnett et al., 1986)], Mx9
IV]/8 (Carrel et al., 1986)], and 3D6 IV]/5
(Lipoldova et al., 1989)], kindly donated from the
producing laboratories. The class I mAb W6/32
was used as a positive control (W6/32.HL) and
its nonbinding variant as a negative control
(W6/32.HK). CD5 was detected using local
reagent TO71, and CD25 (IL-2-receptor o chain)
using TO69. Labeled cells were developed with
FITC-conjugated F(ab)2 rabbit anti-mouse IgG
and analyzed on a FACS IV. Dead cells were
excluded by electronic gating and fluorescence
histograms were area-corrected to 10,000 cells.
Cell Culture
The CD7/CD3 cells sorted from BM of two nor-
mal donors were cloned by limiting dilution in
the presence of pooled allogeneic stimulator cells
with 1000 U/ml IL-2 and PHA. Cells were plated
at 0.45/well directly into Terasaki microplates
containing 104 30 Gy-irradiated pooled PBMC
from more than twenty random normal donors.
Medium was RPMI 1640 supplemented with 10%
human serum (male nontransfused), 1% PHA
(Gibco), and recombinant IL-2 (4x106 U/mg,
courtesy of Biotest Pharma, Dreieich, Federal
Republic of Germany). Contents of positive wells
were transferred to 96-well microtiter plates con-
taining fresh medium and 105 stimulators
between days 7 and 11, and to 24-well cluster
plates with 5x105 stimulators between days 12
and 16. Cultures were given fresh medium every
3 or 4 days and fresh stimulators every 3 weeks
thereafter.
Surface-Marker Phenotyping
Cells preincubated with Intraglobin were labeled
with mAb for CD2 (OKT11), CD3 (OKT3), CD4
(OKT4), and CD8 (OKT8) from the ATCC. MAb
Northern and Southern Blotting for TCR
Analysis
For Northern blot analysis, total cellular RNA
was prepared by extraction with 4M guanid-
inium isothiocyanate (GI) and ultracentrifugation
through a CsC1 cushion (Chirgwin et al., 1979).
Cells were washed twice in cold PBS before lysis.
Each RNA sample was quantified spectrophoto-
metrically by absorbance at 260 and 280nm.
Approximately 12 tg of each total RNA sample
was analyzed by electrophoresis on 1% (w/v)
agarose, 2.2M (w/v) formaldehyde gels. Ethid-
ium bromide (1 tg/ml) was added to each sam-
ple to visualize the ribosomal RNAs. Following
electrophoresis, RNAs were transferred to posi-
tively charged nylon membranes (Hybond N/,
Amersham, UK) and fixed with 0.05 M NaOH for
5 min.
Human cDNA probes were labeled with O32p
dATP (ca. 110TBq/mmol, Amersham) by the
random primer method as described by Feinberg
and Vogelstein (1983) to a specific activity of ca.
10 cpm/tg, pGA5, a kind gift of Dr. D. Mathieu-
Mahul, Paris, is specific for the TCRc chain and
originally derived from the ALL line HPB-MLT
(Sim et al., 1984). This pUC13 subclone containsHUMAN T-CELL DEVELOPMENT IN VITRO 207
the 1.3-kb EcoRI fragment spanning the V-J-C
region and part of the 3’-untranslated region. The
TCR]/-chain-specific cDNA probe pCflREX
(Acuto et al., 1985) was from Dr. H.D. Royer
(Heidelberg) and consists only of C-region
sequences (800 bp EcoRIxBglII in pBR322). The
cDNA probe specific for the TCR, chain was
kindly provided by Dr. T.W. Mak, Ontario, as a
1.6-kb EcoRI insert in pUC13, originally isolated
from a PBMC library, and containing the V-J-C ?’1
region. 0-240, a cDNA probe specific for the
TCR chain (kind gift of Dr. M.S. Krangel,
Boston) spans the C-region and 3’-untranslated
region (1.5-kb EcoRI in pUC18) (Hata et al.,
1987).
Hybridization was performed overnight at
65C in a solution containing 1% BSA, 1 mM Na2-
EDTA, 0.5 M Na2 HPO4 at pH 7.2 and 7% SDS,
according to a method first described by Church
and Gilbert (1984). For rehybridization, the mem-
brane was stripped by washing in 0.1% SDS at
95C for 3 to 5 min.
For Southern blot analysis, high-molecular-
weight genomic DNA was prepared from cell
lines and T-cell clones by standard techniques.
Briefly, the cell lysates were digested with pro-
teinase K and DNA was then purified by extrac-
tion with phenol and precipitation with ethanol.
DNA (5-7.5/g) of each sample was digested
with EcoRI, BamHI, or HindIII (5 U/fig DNA),
size-fractionated on 0.6’to 0.7% agarose gels and
further treated according to Southern (Southern,
1975). The DNA was fixed on Hybond N
/ by alk-
ali treatment (0.4M NaOH, 20 min). Labeling and
hybridization procedures were performed as for
Northern blotting. The same TCR// probe was
also used for both. For analysis of TCR’-chain
rearrangement, a J-region-specific probe (pH60)
was used (kind gift of Dr. T.H. Rabbitts,
Cambridge). This subclone (700-bp HindIIIx
EcoRI in pUC8 [Lefranc and Rabbitts, 1985] was
originally derived from the genomic phage
M13H60.
Proliferation
lx104 cloned cells were incubated with stimulat-
ing agents in round-bottom microtiter plates for
different periods of time, in RPMI medium sup-
plemented with 10% human serum. Proliferation
was quantified by measuring nuclear incorpor-
ation of tritiated thymidine (3H-TdR, Amersham-
Buchler, Braunschweig, specific activity
185 GB/q/mmol used at 37 kBq/well) after a 14-
hr pulse label. Radioactivity was measured by
liquid scintillation counting and data reduction
followed using in-house programs (Schaudt and
Pawelec, 1991). The stimulating agents used were
medium alone or the following human lympho-
kines: IL-2 (Lymphocult T, Biotest, Frankfurt;
activity standardized against the WHO-BRMP-
NIH control), IL-4 (kind gift of Dr. M. Schreier,
Sandoz, Basel; specific activity lx108 U/mg
protein), IL-3 and GM-CSF (courtesy of Drs. F.
Seiler and B. Krumwieh, Behring-Werke,
Marburg; both at ca. 107 U/mg protein), and IL-7
(purchased from Biosource International,
Westlake Village, CA; specific activity lx
107 U/mg protein), or PHA (Gibco), B-lymphob-
lastoid cell lines (B-LCL) expressing various HLA
class II antigens including HLA-Dw 1-10, 12, 14,
and "HAG." Mouse L cells transfected with
human HLA-DR genes were also used as stimu-
lators in some experiments. These transfectants
were obtained through the 11th International
Histocompatibility Workshop.
In some experiments, attempts were made to
block autocrine proliferation with neutralizing
antibodies against IL-lo, IL-1]/, or IL-2 (all affin-
ity-purified goat anti-human IgG from British
Biotechnology), or with a CD25 mAb (local
reagent TO69).
Cytotoxicity
Standard 51Cr-release assays were employed to
measure cell-mediated cytotoxicity. 2-4x106 tar-
get cells were incubated with 3.7xl06kBq of
sodium 51chromate (Amersham) for 90min at
37C, followed by repeated washing and use at 2
x103 cells/well. Experiments were carried out in
U-bottom microtiter plates with at least four dif-
ferent ratios of effector to target cells. After 4 hr,
cell-free supernatant was collected and radio-
activity quantified in a /, counter. Spontaneous
51Cr release and maximum release were deter-
mined in each experiment. The data were col-
lected and reduced to a single-value expression
of cytolytic activity using the lytic units calcu-
lation (Schaudt and Pawelec, submitted for
publication), where one LU was defined as the
number of effectors per 107 cells resulting in 25%
specific isotope release from 2000 target cells.208 H. POHLA et al.
Cytokine Secretion
Cloned cells and 80 Gy-irradiated B-LCL were
cocultured at 5105/ml in 16-mm-diameter cul-
ture plate wells for 24 or 48 hr with or without
1% PHA. Cell-free supernatants were collected
for cytokine bioassay and immunoassay.
Granulocyte/macrophage colony-stimulating
factor (GM-CSF) was measured using an in-
house ELISA with reagents from Genzyme: mic-
rotifer plates were coated with anti-GM-CSF
catching antibody overnight at 4C and the
remaining sites blocked with 1% bovine serum
albumin for 1 hr. Test samples and standard GM-
CSF controls were incubated at room tempera-
ture for 90 rain, followed by addition of anti-GM-
CSF serum and visualization using the peroxi-
dase-conjugated goat anti-rabbit F(Ab)2IgG and
phenylenediamine/H202 solution. The sensitivity
of the assay was approximately 0.1 U/ml (where
one unit is the amount required to generate one
colony [50 cells] from 7.5104 normal human BM
cells in soft agar over 14 days). There was no
cross-reactivity with IL-3 or G-CSF. Tumor
necrosis factor (TNF-c) was quantified using a
commercial IRMA from Medgenix (DiJsseldorf,
FRG), with a sensitivity of 10pg/ml and no
cross-reactivity on TNF-]/, IL-1, IL-2, or inter-
ferons. T-cell growth factors were measured in
bioassays by titrating test supernatants onto fac-
tor-dependent T-cell lines, and assaying prolifer-
ation compared to titrated amounts of standard
IL-2. Although not proven, it is assumed that the
majority of the proliferation observed is caused
by IL-2.
Detection of Cytokines at the mRNA Level
RNA was isolated from cloned cells by a modifi-
cation of the method of Chomczynski and Sacchi
(1987) after stimulation with 1% PHA and 80 Gy-
irradiated LCL for 5 hr. Briefly, cells were lysed
in guanidinium isothiocyanate buffer (4M GI,
20 mM sodium acetate at pH 5.2, 0.1 mM dithi-
othreitol, and 0.5% N-laurylsarcosine). Then 2M
sodium acetate (pH 4.0), water-saturated phenol,
and chloroform:isoamyl alcohol (49:1) were
sequentially added, vortexed, and chilled on ice
for 15 min. Phases were separated by centrifug-
ation at 10,000 g for 20 min at 4C. RNA was pre-
cipitated from the aqueous supernatant with iso-
propyl alcohol, washed with 70% ethanol, dried,
and dissolved in water. 0.5/g of total RNA was
reverse transcribed by addition of 0.1 by volume
of 10xPCR reaction buffer (100 mM Tris-HC1 at
pH 8.3, 500mM KC1, 15 mM MgC12, and 0.01%
gelatine), 0.5/g oligo-dT-Primer (Gibco-BRL),
0.2mM of each deoxynucleotide (Perkin-Elmer
Cetus, Norwalk, CT) 20 U rRNasin RNase inhibi-
tor (Promega), and 200 U of Moloney-murine leu-
kemia virus reverse transcriptase (Gibco-BRL).
The reaction proceeded at 42C for 1 hr and was
terminated by heating to 95C for 5 min.
Eighty microliters of lxPCR-buffer containing
20pmol each of upstream and downstream
primer and 1 U of Taq DNA polymerase (Perkin-
Elmer Cetus) were added to the 20/1 of reverse
transcriptase reaction mixture and overlaid with
mineral oil. The reaction was carried out in a Bio-
Med Thermocycler 60 (Bachofer, FRG) with the
following cycling parameters: 1 min at 95C
(denaturation), 1 min at 60C (annealing), and
2 min at 72C (extension) for 30 cycles, followed
by an additional 5 min at 72C. To analyze the
specific sizes of the amplification products, 20-/1
aliquots were electrophoresed on 2% agarose
gels, stained with ethidium bromide, and com-
pared with molecular-weight standards.
The sequences of the primers used to detect the
mRNA transcripts coding for IL-3, IL-4, IFN-y,
GM-CSF, and fl-actin were taken from Ehlers and
Smith (1991), and for IL-2 from Wieder et al.
(1990). The primer pair for IL-9 was deduced
from the published human IL-9 sequence (Yang
et al., 1989) for which the sense primer corre-
sponded to nucleotide 9-29 (5’-CTGTCAAG-
ATGCTTCTGGCCA-3’) and the antisense primer
to 363-384 (5’-GTCAGCGCGTTGCCTGCCGTGG-
3’). The specificity of the amplification process
was determined by Southern blot analysis of the
derived fragment using a 489-bp EcoRIxHindIII
cDNA probe, a kind gift of Dr. J. van Snick,
Brussels (Renauld et al., 1990). All primers were
synthesized on a Pharmacia Gene Assembler
Plus and purified by NApTM10 columns
(Pharmacia LKB, Sweden).
Suppression
Cloned cells were irradiated at 20 Gy and titrated
into MLC between autologous or allogeneic
PBMC as responding cells and a 30 Gy-irradiated
pool (>20 donors) as stimulators. MLC consisted
of 5x104 responders and an equal number ofHUMAN T-CELL DEVELOPMENT IN VITRO 209
stimulators in round-bottom microtiter plates
with medium containing 10% human serum.
After 5 days, 37-kBq 3H-TdR/well were added
and cultures harvested for ]/-scintillation coun-
ting 14 hr later. Controls consisted of responder
PBMC alone, and MLC in the absence of added
cloned cells.
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